ItalyABLE Biosciences is a trademark of Bioindustry Park Silvano Fumero S.p.A. which offers quantitative and qualitative analysis of small molecules, peptides, proteins, including protein biomarkers.

Rome, Lazio ItalyAdaltis offers diagnostic reagent kits such as tests for hormones, tumour markers, fertility, autoimmune, and infectious disease.

Via Luigi Einaudi 7 Guidonia di Montecelio Rome, 00012 ItalyAdaltis offers diagnostic reagent kits such as tests for hormones, tumour markers, fertility, autoimmune, and infectious disease.

Via Pontina km 30.600, c/o IRBM Science Park Pomezia, Rome, 00071 ItalyAdvaxia Biologics, part of the IRBM group, is a cGMP Contract Development & Manufacturing Organization (CDMO), located near Rome (Pomezia) Italy, compliant with the regulatory guidelines of the EMA, MHRA and FDA. Advaxia's integrated contract services portfolio includes outstanding support in the areas of analytical method development, process development/validation, in-process assay development & qualification, GMP Manufacture, full QC product release, ICH Stability and cell banking. Advaxia is dedicated to the development and production of clinical lots of recombinant adenoviruses to support clinical trials for vaccine and gene therapy applications. The Advaxia team has built an outstanding track record in the production of clinical lots for many infectious diseases, including Ebola, HIV and supported the global effort to expedite delivery of a COVID-19 vaccine.

Frazione Pantalla di Todi - 06059 Perugia - ItalyBioTecnologie BT, with its 2 GLP and GEP Research Centres, is able to provide its Customers with a complete and competitive range of activities and studies, in order to support the registration dossier of different kinds of products: Plant Protection Products Veterinary Medicinal Products Biocides Pharmaceutical Products All tests are performed in compliance with current International Guidelines (OECD, IOBC/WPRS, ESCORT, CIPAC, ICH etc). BioTecnologie BT, thanks to a long experience, consolidated know-how and highly qualified staff, can guarantee a quality performance to suit customer needs. The Company, with its 2 Research Centres situated in Central and Northern Italy, offers cuttingedge equipment extending over a total area of 3000 m2 including laboratories, greenhouses and an Insectarium, amongst the largest in Europe.

ItalyBouty meets market and consumers' needs with a five (5) division division structure; Healthcare, Diagnostics, Biotechnology, Drug Delivery Systems, International.

Via Appia km. 65,561 04013 Latina Scalo (Lt) - ItalyBSP Pharmaceuticals specializes in the development and manufacturing of cytotoxic drugs.

Latina Scalo, Lazio ItalyBSP Pharmaceuticals specializes in the development and manufacturing of cytotoxic drugs.

Via della Ricerca Scientifica Edificio PP2 Rome, 00133 ItalyC4T offers computation chemistry, custom synthesis, and analytical chemistry services.

VIA COLUMBIA, 2 ROMA LAZIO, RM, 00133 Italy

Viale Roma 120 Guidonia Montecelio, 00012 ItalyCliniSciences is a European distributor of products & services from suppliers based all around the world. With a direct presence in 18 countries, CliniSciences serves customers through its own commercial and technical teams in Austria, Belgium, Denmark, Finland, France, Germany, Iceland, Ireland, Italy, the Netherlands, Norway, Poland, Portugal, Spain, Sweden, Switzerland, the United Kingdom, and the United States. Through these companies, CliniSciences offers a broad portfolio of life science reagents, instruments and services for research and diagnostic applications. Our product range includes reagents, antibodies, cells, assay kits, instruments, and a strong offering of human biological samples, including blood-derived products, tissues, primary cells, biofluids, DNA/RNA and other clinically relevant biospecimens. Our services include antibody development, peptide and protein synthesis, bulk manufacturing, humanization, custom production and other tailored solutions to support life science, biotech and diagnostic projects.

Via Pinerolo 2 Roma, Roma, 00182 ItalyLearn how we ignite Clinical and Professional Development in the Life Sciences industry. At the heart of CRES lies a mindset to stay open to cooperating with everyone, from patient association representatives to clinicians, life science companies and policy and decision-makers. We aim to foster innovation in healthcare and fill the gap in access to medical treatments and healthcare services. A track record of successful services & training: CRES was born from the merger between Cres Academy and Cres Trials, CRES supports companies in their approach to clinical research and commercialization, allowing them to modernize and speed up the identification of impactful solutions.

20 Via Ufente Latina, Lazio, 04100 ItalyCSV Pharma Service is part of CSV Life Science Group, an international company specializing in consulting services and innovative solutions for the Life Sciences sector, including Secondary Pharmaceuticals, Medical Devices, Laboratories, APIs, Fine Chemicals, and Food. Thanks to its synergy with the group, it offers clients a network of expertise and resources capable of supporting complex projects, with a global approach that is also responsive to local needs. Its mission is to support companies through all phases of a project's life cycle, ensuring quality, efficiency, regulatory compliance, and timeliness. Furthermore, it offers engineering and validation services, project management, and activity coordination, ensuring a technical, integrated, and quality-oriented approach.

32 Via Ercole Ramarini Monterotondo, Lazio, 00015 ItalyExtensive information about the sequence of both human and mouse DNA suggests that mouse and human genes are similar and appear to serve similar functions to the extent that changes in the equivalent gene usually leads to similar inherited diseases. Our unit provides services for the production of genetically modified mice to be used as models to understand human diseases. The creation of genetically altered mice requires specialized techniques and central provision has significant advantages by providing a pool of experience and expertise that reduce and refine the numbers of mice required to generate new genetically altered lines. At the Transgenic Service Facility of EMBL-Monterotondo, many gene targeting projects, DNA injection projects and mouse line rederivations are completed every year and for such purpose, our Transgenic Service unit provides a wide spectrum of standard and advanced alternative techniques. Our service produces many lines of mice and many more are imported from centres around the world.

EMBL Monterotondo, Adriano Buzzati-Traverso Campus, Via Ramarini 32, 00016 Monterotondo, ItalyExtensive information about the sequence of both human and mouse DNA suggests that mouse and human genes are similar and appear to serve similar functions to the extent that changes in the equivalent gene usually leads to similar inherited diseases. Our unit provides services for the production of genetically modified mice to be used as models to understand human diseases. The creation of genetically altered mice requires specialized techniques and central provision has significant advantages by providing a pool of experience and expertise that reduce and refine the numbers of mice required to generate new genetically altered lines. At the Transgenic Service Facility of EMBL-Monterotondo, many gene targeting projects, DNA injection projects and mouse line rederivations are completed every year and for such purpose, our Transgenic Service unit provides a wide spectrum of standard and advanced alternative techniques. Our service produces many lines of mice and many more are imported from centres around the world.

Via Tito Speri, 12/14 Pomezia, 00071 ItalyERBC Group is a leading CRO committed to bridge the gap between discovery, preclinical and clinical development by evaluating the efficacy and safety of new compounds including new therapies, drugs, medical devices, chemicals, agro-chemicals and cosmetics. Offering a comprehensive range of innovative models and services, regulatory pre-IND package and consultancy services, ERBC Group allows biopharmaceutical and chemical industry professionals to de-risk innovation and enhance R&D productivity.

Adriano Buzzati-Traverso Campus, Via Ramarini 32 00015 Monterotondo, ItalyOur research is focused on the study of critical mammalian physiological phenomena from a molecular perspective in the context of the whole organism. The Unit is composed of independent research groups whose work is bound together by the study of the mouse in vivo as the principle experimental organism and the application of state-of-the-art methods for genetic and epigenetic perturbation of cellular and physiological function. Recent advances in gene delivery and modification technology have dramatically increased the ease and rapidity with which genetic and epigenetic perturbations can be introduced into the mouse genome allowing increasingly sophisticated causal experimental approaches in this organism. Currently research groups at EMBL Monterotondo are investigating the epigenetic control of early development, blood cell development and differentiation, neural circuits and behavior, neural computation, and somatosensation. A major and continuing effort is underway to increasingly centre research activities at the Unit around neurobiology and epigenetics.

Via Castelfidardo, 8, 00185 Roma

Via G. Peroni, 386 Loc. Tecnopolo Tiburtino 00131 – Roma ItalyEXPLORA S.r.l. is a privately owned Italian company established in 2006 at the Technological Park “Tecnopolo Tiburtino” in Rome by a pool of young researchers and the support of a French seed capital organization INVENT SaS. EXPLORA is committed to the development of enabling technologies for biological engineering Vision Biology is going through a radical paradigm shift over the last decade evolving from a qualitative/descriptive science to quantitative/engineering one. It’s now possible to “(a) design and construct new biological parts, devices and systems and (b) re-design existing, natural biological systems for useful purposes” in a rational and systematic way. This forward biological engineering approach may be applied at all levels of the hierarchy of biological structures: from individual molecules to whole cells, tissues, organisms and populations. This approach, also known as synthetic or constructive biology, has already revolutionized technology and production paradigms fostering the development of innovative medicines, redesign environmental friendly chemical processes and generate new sources of energy. Mission Our mission is to develop innovative enabling technologies to unlock the full potential of forward biological engineering. Our ultimate goal is to develop a comprehensive and coherent bio-engineering platform to allow scientist to pursue their ambitious goals. Strategy Our strategy is built around the following words: research-develop-deliver. Since inception we have been constantly investing in R&D to develop next generation technology through tailored partnerships. We are currently involved in several research projects and we constantly seek scientific partnerships to broaden and strengthen our expertise.

Via G. Peroni, 386 Loc. Tecnopolo Tiburtino Roma, 00131 ItalyEXPLORA S.r.l. is a privately owned Italian company established in 2006 at the Technological Park “Tecnopolo Tiburtino” in Rome by a pool of young researchers and the support of a French seed capital organization INVENT SaS. EXPLORA is committed to the development of enabling technologies for biological engineering Vision Biology is going through a radical paradigm shift over the last decade evolving from a qualitative/descriptive science to quantitative/engineering one. It’s now possible to “(a) design and construct new biological parts, devices and systems and (b) re-design existing, natural biological systems for useful purposes” in a rational and systematic way. This forward biological engineering approach may be applied at all levels of the hierarchy of biological structures: from individual molecules to whole cells, tissues, organisms and populations. This approach, also known as synthetic or constructive biology, has already revolutionized technology and production paradigms fostering the development of innovative medicines, redesign environmental friendly chemical processes and generate new sources of energy. Mission Our mission is to develop innovative enabling technologies to unlock the full potential of forward biological engineering. Our ultimate goal is to develop a comprehensive and coherent bio-engineering platform to allow scientist to pursue their ambitious goals. Strategy Our strategy is built around the following words: research-develop-deliver. Since inception we have been constantly investing in R&D to develop next generation technology through tailored partnerships. We are currently involved in several research projects and we constantly seek scientific partnerships to broaden and strengthen our expertise.

73 Via Lago Dei Tartari Albuccione, Lazio, 00012 ItalyFarm srl was established from the union of pre-existing companies (FARM sas) and independent professionals whose activity takes off in 1985. Farm srl grows on average 15% per year and invests about 20% of its turnover in new structures, equipments and training. The staff is hired in full with permanent contracts and includes graduates in chemistry, industrial chemistry, environmental engineering, biomedical engineering, chemical engineering, biology and agronomy. The company is divided into the following departments: LAB-01 Water; LAB 02 Emissions and Working/Living Environments; LAB 03 Foods; LAB 04 Wastes and Soils; LAB 05 Raw materials and Fine products for Pharmaceutical, Chemical, Cosmetic and other companies; Engineering and Technical assistance. The laboratory is divided into the following activities: Basic Chemistry, Inorganic Chemistry 1 (Metals, Elementary Analysis), Inorganic Chemistry 2 (Anions, Hydrocarbons), Organic Chemistry, Microbiological and Physical. The instrumentation is at the forefront, and always renewed. Sample registration, their processing, certification and archiving are automated and managed by a specific software. Customers are able to consult and export their own analytical results by means a virtual platform. Beside the analytical controls Farm srl ensures qualified technical assistance directly in the field owing to its Engineering and Technical assistance departments.

Amelia, Umbria, 05022 ItalyFarm srl was established from the union of pre-existing companies (FARM sas) and independent professionals whose activity takes off in 1985. Farm srl grows on average 15% per year and invests about 20% of its turnover in new structures, equipments and training. The staff is hired in full with permanent contracts and includes graduates in chemistry, industrial chemistry, environmental engineering, biomedical engineering, chemical engineering, biology and agronomy. The company is divided into the following departments: LAB-01 Water; LAB 02 Emissions and Working/Living Environments; LAB 03 Foods; LAB 04 Wastes and Soils; LAB 05 Raw materials and Fine products for Pharmaceutical, Chemical, Cosmetic and other companies; Engineering and Technical assistance. The laboratory is divided into the following activities: Basic Chemistry, Inorganic Chemistry 1 (Metals, Elementary Analysis), Inorganic Chemistry 2 (Anions, Hydrocarbons), Organic Chemistry, Microbiological and Physical. The instrumentation is at the forefront, and always renewed. Sample registration, their processing, certification and archiving are automated and managed by a specific software. Customers are able to consult and export their own analytical results by means a virtual platform. Beside the analytical controls Farm srl ensures qualified technical assistance directly in the field owing to its Engineering and Technical assistance departments.

Via Ardeatina, 306 – Rome, 00179 ItalyPreclinical Research and Translational Sciences The Santa Lucia Foundation conducts research in the field of neuroscience. This research is preclinical and translational, meaning designed to result in a rapid implementation of its findings to actual patient care. The research activity is a core element of Santa Lucia’s Mission. Since1992, the Ministry of Health has recognized the Foundation as a fully qualified Institute for Research and Health Care (IRCCS). The activity of individual laboratories is coordinated within six research lines. Laboratories and Scientific Productivity Fifty laboratories are involved in the entire research area of activity of the Foundation. Regarding the scientific productivity, which is calculated by means of the international standard of Impact Factor, Santa Lucia Foundation is ranked number one in Italy in the Neurosciences field (Source: Italian Department of Health). Specifically, the current normalized Impact Factor of scientific production of the Foundation is 2,112.50 scores (2014). CERC The laboratories of the Foundation are both housed within the hospital and its wards, and also at the European Centre for Brain Research (Centro Europeo di Ricerca sul Cervello – CERC), a short distance from the campus of the Foundation. The CERC research activities and collaborations serve to highlight the institutions commitment to providing scientists with the resources, spaces and technologies appropriate to the research mission and objectives. The facility has been made possible to realize important synergies with research centers and universities both in Italy and internationally. Particularly important are the partnerships with Sapienza University of Rome, Tor Vergata University of Rome and Campus Bio-Medico University.

Via Ardeatina, 306 – 00179 Rome ItalyPreclinical Research and Translational Sciences The Santa Lucia Foundation conducts research in the field of neuroscience. This research is preclinical and translational, meaning designed to result in a rapid implementation of its findings to actual patient care. The research activity is a core element of Santa Lucia’s Mission. Since1992, the Ministry of Health has recognized the Foundation as a fully qualified Institute for Research and Health Care (IRCCS). The activity of individual laboratories is coordinated within six research lines. Laboratories and Scientific Productivity Fifty laboratories are involved in the entire research area of activity of the Foundation. Regarding the scientific productivity, which is calculated by means of the international standard of Impact Factor, Santa Lucia Foundation is ranked number one in Italy in the Neurosciences field (Source: Italian Department of Health). Specifically, the current normalized Impact Factor of scientific production of the Foundation is 2,112.50 scores (2014). CERC The laboratories of the Foundation are both housed within the hospital and its wards, and also at the European Centre for Brain Research (Centro Europeo di Ricerca sul Cervello – CERC), a short distance from the campus of the Foundation. The CERC research activities and collaborations serve to highlight the institutions commitment to providing scientists with the resources, spaces and technologies appropriate to the research mission and objectives. The facility has been made possible to realize important synergies with research centers and universities both in Italy and internationally. Particularly important are the partnerships with Sapienza University of Rome, Tor Vergata University of Rome and Campus Bio-Medico University.

Via Ignazio Guidi n. 3 ROMA, RM, 00147 Italy

Via Ignazio Guidi n. 3 Rome, RM, 00147 Italy

Rome, Lazio ItalyGenechron offers DNA sequencing, next generation sequencing, custom primer synthesis, metabonomic profiling, and bioinformatics services.

Via Anguillarese, 301 Rome, 00123 ItalyGenechron offers DNA sequencing, next generation sequencing, custom primer synthesis, metabonomic profiling, and bioinformatics services.

Italy

a Castagnetta 7 00040 Pomezia (Rome), ItalyInjectalia offers manufacturing for vials, syringes, hard capsules, tablets, powder and sachets.

Via Pontina Km 30,600 Pomezia, 00071 ItalyIRBM is a scientific contract research organization (CRO) that stands at the forefront of drug discovery, leveraging a single, unified research facility to accelerate team-based breakthroughs and improve efficiencies from concept to candidate. With a history of contributing to several approved drugs, and its own internal pipeline of oncology and other therapeutic assets, IRBM is powered by deep collaborations and decades of expertise from leading global institutions. Their comprehensive in-house capabilities assist partners in achieving key milestones and progressing toward clinical readiness, positioning IRBM as a major player in driving innovation in the pharmaceutical and biotech fields. We Make Drugs. IRBM's team has a notable track record, developing 3 marketed therapeutics: ISENTRESS®, the first-in-class HIV integrase inhibitor Grazoprevir, part of the HCV ZEPATIER® combination therapy ZEJULA®, a PARP inhibitor for the treatment of ovarian cancer

Largo dei Lombardi 4 Rome, 00186 ItalyISIS, the Institute of Studies for the Integration of Systems, is an independent Italian research institute supporting international, national and local public bodies for the analysis, the design, the implementation and the evaluation of sustainable policies in the fields of energy, environment, transport and mobility, urban planning, and knowledge society. For more than four decades ISIS has supplied expertise and solved complex problems for a variety of public and private organisations, and notably for the European Commission. Founded in 1971, ISIS relies on the expertise of a multi-disciplinary team – including engineers, statisticians, experts in information technology, social scientists, and economists – and avails itself of state-of-the-art information technologies, also developing its own interactive and user-friendly software applications. ISIS has extensive experience in the management of and participation in EU funded projects in FP4, FP5, FP6 and FP7, and has a well-established network of alliances currently active in the Europe and beyond. ISIS has extensively worked in the field of policy impact assessment, with particular reference to socio-economic impacts and through the development and application of forward looking analysis (FLA) methods and tools. ISIS has played an important role in the conception and implementation of some of the most significant projects carried out in Europe, partecipating, both as leader and as partner, in over 80 European projects. The global mind-set of our staff and the ability to work in several languages provide a unique added value to both our international and Italian clients.

Via Fossignano, 2 04011 Aprilia (LT) ItaliaIstituto Biochimico Italiano (ibi) provides manufacturing of recombinant proteins and pharmaceutical products.

Via Fossignano Fossignano, Lazio, 04011 ItalyIstituto Biochimico Italiano (ibi) provides manufacturing of recombinant proteins and pharmaceutical products.

299 Viale Regina Elena, Roma, Lazio 00161, ITThe Institute's main entrance is located in Viale Regina Elena n. 299, Rome, in front of the Campus. Secondary entrances are located in Via del Castro Laurentian n. 10 and n. 25 and in Piazzale Valerio Massimo n. 5. A headquarters is located in Via Giano della Bella n. 34.

Pontina, 5 km 29 - 00040 Pomezia - Rome - ItalyItalchimici specializes in the manufacturing and marketing of prescription medicines.

291 Viale Regina Elena, Roma, Lazio 00161, ITThe IIT@Sapienza laboratory, born after a Research Project CLNS submitted in 2010, revolves around two topics of biomedical interest where technological innovation is key to reach the goals. The first regards neurodegenerative disorders, hereditary and sporadic conditions characterized by progressive nervous system dysfunction. The focus of the second will be brain tumours, the most life-threatening diseases of adulthood and childhood. These challenging projects benefit from the establishment and convergence of common technological platforms. They avail themselves of state-of-the-art commercial equipment and, at the same time, foster and support the development of new techniques and instrumentation.

Via Gaudenzio Fantoli 16/15NeED Pharmaceuticals supports discovery research and antimicrobial discovery by providing MIC/MBC, microbial quantitation, and resistance development services.

Rome, Lazio ItalyOkairos develops genetic vaccines and GMP manufacturing services.

34 Via di Grotte Portella Lazio, 00044 ItalyParticle Measuring Systems offers particle counting, microbial monitors, gas analysis, and laboratory testing.

Via di Grotte Portella, 34 Frascati, Roma, 00044 ItalyParticle Measuring Systems offers particle counting, microbial monitors, gas analysis, and laboratory testing.

Via Morolense 87 03013 Ferentino (FR) ItalyPatheon is the leading publicly listed provider of drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies.

ItalyReact4life performs realistic, controlled, and reproducible tests in a 3D human and dynamic environment in vitro. By using the MIVO® - Multi In Vitro Organ on chip platform, we carry out cellular based assay by recapitulating the physiological flow conditions and 3D real tissues complexity in vitro, for more reliable and predictive readouts. React4life may both (i) sell the MIVO platform and support the customer during the first adoption, with video tutorial, scientific calls etc, (ii) provide MIVO based in vitro service activities for exploratory assays, drug efficacy assays, cytotoxicity, or permeation assays. In particular, the R&D team has deep experience in cellular biology, cancer biology and immunology.

Via Tito Speri, 12 Rome I-00040 ItalyResearch Toxicology Centre offers mammalian toxicology, kinetic studies, bioavailability, dose studies, and histopathology.

Via Tito Speri 12/14 Rome, Lazio, 00071 ItalyResearch Toxicology Centre offers mammalian toxicology, kinetic studies, bioavailability, dose studies, and histopathology.

Via Castelli Romani, 22 00040 Pomezia RM ItalySo.Se.PHARM provides discovery, development and sale of pharmaceutical products.

Via di Castel Romano,100 Rome, 00128 ItalyLeveraging on the long standing experience of our scientists in the Pharma sector, Takis as CRO provides high quality services in Oncology, Immunology and Infectious Diseases. Custom antibodies generation and production, protein production, animal models, drug discovery and development services are our daily activities.

Via Varese 16b - 00185 Roma, ItaliaThe Telethon Network of Genetic Biobanks (TNGB) has been founded in 2008 by 7 Biobanks supported by Telethon Foundation, whose purpose is to collect, preserve and offer to the Scientific Community biological samples and related clinical data from individuals affected by genetic diseases, from their relatives or from healthy control individuals. TNGB also offers its services to Patients’ Associations. At present, the Network is constituted of 11 Biobanks. The aim of the Network is to coordinate and manage the Biobanks' activities in order to enhance synergy and provide scientists with an effective service responding to the highest quality standards, according to rigorous ethical principles complying with Italian laws and International Recommendations. Over the years, national and international scientists have extensively used the TNGB with different purposes. The complete list of the scientific publications acknowledging the TNGB services is available here. At the European level, TNGB is partnering with EuroBioBank Network and since its inception the Network has joined as associated member the pan-European research infrastructure BBMRI. Since 2014, all Biobanks of the Network have been admitted to the Italian Node (BBMRI-IT) and have signed the BMMRI-IT Partner Charter. TNGB also is one of the associated partners of the European RD-connect project aimed at connecting databases, registries, biobanks and clinical bioinformatics for rare disease research.

Via Varese 16b Roma, 00185 ItalyThe Telethon Network of Genetic Biobanks (TNGB) has been founded in 2008 by 7 Biobanks supported by Telethon Foundation, whose purpose is to collect, preserve and offer to the Scientific Community biological samples and related clinical data from individuals affected by genetic diseases, from their relatives or from healthy control individuals. TNGB also offers its services to Patients’ Associations. At present, the Network is constituted of 11 Biobanks. The aim of the Network is to coordinate and manage the Biobanks' activities in order to enhance synergy and provide scientists with an effective service responding to the highest quality standards, according to rigorous ethical principles complying with Italian laws and International Recommendations. Over the years, national and international scientists have extensively used the TNGB with different purposes. The complete list of the scientific publications acknowledging the TNGB services is available here. At the European level, TNGB is partnering with EuroBioBank Network and since its inception the Network has joined as associated member the pan-European research infrastructure BBMRI. Since 2014, all Biobanks of the Network have been admitted to the Italian Node (BBMRI-IT) and have signed the BMMRI-IT Partner Charter. TNGB also is one of the associated partners of the European RD-connect project aimed at connecting databases, registries, biobanks and clinical bioinformatics for rare disease research.

Via Costarica, 20/22 - 00040 Pomezia (Roma) ItalyTubilux Pharma specializes in designing, developing and producing ophthalmic drugs.

Pomezia, Lazio, 00040 ItalyTubilux Pharma specializes in designing, developing and producing ophthalmic drugs.

Piazzale Aldo Moro 5 Roma, 00185 Italy

ItalyValagro was founded in Abruzzo and brings into the world of today the same passion for nature that produces its solutions for the care and nurture of plants. Today, our company is able to globally respond to the specific needs of the Customer, needs that reflect new and increasing requirements, in a context of increasingly scarce and precious resources. For this reason, here at Valagro, we have decided to accept a challenge: to bring development and prosperity using fewer resources, or rather to produce more and better for the needs of the world, using less land, less water and less technical means. To do this, we have placed research and innovation in the service of nature, understanding that taking care of the future means working together while respecting the environment and protecting the health of everyone.

viale Bruno Buozzi, 59 - 00197 Roma - ItalyVI.REL Pharma offers phase II-IV clinical research services including clinical development, regulatory affairs, quality assurance, and scientific writing.

Viale Giorgio Ribotta Via Giorgio Ribotta n.21 Roma, Lazio, 00144 ItalyWorldwide Clinical Trials employs more than 1,600 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From Early Phase and Bioanalytical Sciences through Late Phase and post approval, we provide world-class, full-service drug development services. With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO.